Lower extremity arthroplasty in patients with inflammatory arthritis: Preoperative and perioperative management

Journal of the American Academy of Orthopaedic Surgeons

Volumn 21, Issue 6, 2013, Pages 355-363

  Goodman, Susan M ^a   Figgie, Mark ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTHRITIS; CARDIOVASCULAR DISEASE; DRUG ANTAGONISM; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; LUNG DISEASE; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; REVIEW; SURGICAL INFECTION;

ADRENAL CORTEX HORMONES; ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CARDIOVASCULAR DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; PERIOPERATIVE CARE; PREOPERATIVE CARE; SURGICAL WOUND INFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878579458     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-21-06-355     Document Type: Review

References (74)

1. Benoni AC, Bremander A, Nilsdotter A: Patient-reported outcome after rheumatoid arthritis-related surgery in the lower extremities: A report from the Swedish National Register of Rheuma Surgery (RAKIR). Acta Orthop 2012; 83(2):179-184.
2. Urban MK, Jules-Elysee K, Loughlin C, Kelsey W, Flynn E: The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J 2008;4(1):76-80.
3. Bongartz T, Halligan CS, Osmon DR, et al: Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum 2008;59(12):1713-1720.
4. Stern SH, Insall JN, Windsor RE, Inglis AE, Dines DM: Total knee arthroplasty in patients with psoriasis. Clin Orthop Relat Res 1989;(248):108-111.
5. Braun J, van den Berg R, Baraliakos X, et al: 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011;70(6):896-904.
6. Zochling J, van der Heijde D, Burgos- Vargas R, et al: ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65(4):442-452.
7. Sundaram NA, Murphy JC: Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop Relat Res 1986;(207):223- 226.
8. Eggli S, Woo A: Risk factors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg 2001;121(9):531-535.
9. Kanathur N, Lee-Chiong T: Pulmonary manifestations of ankylosing spondylitis. Clin Chest Med 2010;31(3):547-554.
10. Gladman DD, Chandran V: Observational cohort studies: Lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011;50(1):25-31.
11. Ritchlin CT, Kavanaugh A, Gladman DD, et al: Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68(9):1387-1394.
12. Michet CJ, Mason TG, Mazlumzadeh M: Hip joint disease in psoriatic arthritis: Risk factors and natural history. Ann Rheum Dis 2005;64(7): 1068-1070.
13. Menon TJ, Wroblewski BM: Charnley low-friction arthroplasty in patients with psoriasis. Clin Orthop Relat Res 1983; (176):127-128.
14. Beyer CA, Hanssen AD, Lewallen DG, Pittelkow MR: Primary total knee arthroplasty in patients with psoriasis. J Bone Joint Surg Br 1991;73(2):258- 259.
15. Hession MT, Gottlieb AB: Perioperative management of tumor necrosis factor antagonists in patients with psoriasis and other inflammatory disorders. J Dermatolog Treat 2011;22(2):90-101.
16. Hsu S, Papp KA, Lebwohl MG, et al: Consensus guidelines for the management of plaque psoriasis. Arch Dermatol 2012;148(1):95-102.
17. Brook I: Secondary bacterial infections complicating skin lesions. J Med Microbiol 2002;51(10):808-812.
18. Hanssen AD, Spangehl MJ: Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res 2004;(427):79-85.
19. Saini R, Shupack JL: Psoriasis: To cut or not to cut, what say you? Dermatol Surg 2003;29(7):735-740.
20. Hochberg MC: Adult and juvenile rheumatoid arthritis: Current epidemiologic concepts. Epidemiol Rev 1981;3:27-44.
21. Spector TD: Rheumatoid arthritis. Rheum Dis Clin North Am 1990;16(3): 513-537.
22. Pincus T, Sokka T, Kautiainen H: Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52(4):1009- 1019.
23. Hekmat K, Jacobsson L, Nilsson JA, et al: Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis: Results from a well defined population in south Sweden. Arthritis Res Ther 2011;13(2):R67.
24. Massardo L, Gabriel SE, Crowson CS, O'Fallon WM, Matteson EL: A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis. J Rheumatol 2002; 29(1):52-56.
25. Kapetanovic MC, Lindqvist E, Saxne T, Eberhardt K: Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: Prevalence and predictive factors of large joint replacement. Ann Rheum Dis 2008;67(10):1412-1416.
26. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE: Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002;46(9):2294-2300.
27. Au K, Reed G, Curtis JR, et al: High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis 2011;70(5):785-791.
28. Neva MH, Häkkinen A, Mäkinen H, Hannonen P, Kauppi M, Sokka T: High prevalence of asymptomatic cervical spine subluxation in patients with rheumatoid arthritis waiting for orthopaedic surgery. Ann Rheum Dis 2006;65(7):884-888.
29. Kauppi M, Neva MH: Sensitivity of lateral view cervical spine radiographs taken in the neutral position in atlantoaxial subluxation in rheumatic diseases. Clin Rheumatol 1998;17(6): 511-514.
30. Kauppi MJ, Neva MH, Laiho K, et al: Rheumatoid atlantoaxial subluxation can be prevented by intensive use of traditional disease modifying antirheumatic drugs. J Rheumatol 2009; 36(2):273-278.
31. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD: Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56(8):2708-2714.
32. Neva MH, Myllykangas-Luosujärvi R, Kautiainen H, Kauppi M: Mortality associated with cervical spine disorders: A population-based study of 1666 patients with rheumatoid arthritis who died in Finland in 1989. Rheumatology (Oxford) 2001;40(2):123-127.
33. Wolfs JF, Kloppenburg M, Fehlings MG, van Tulder MW, Boers M, Peul WC: Neurologic outcome of surgical and conservative treatment of rheumatoid cervical spine subluxation: A systematic review. Arthritis Rheum 2009;61(12): 1743-1752.
34. Bayar N, Kara SA, Keleş I, Koç C, Altinok D, Orkun S: Cricoarytenoiditis in rheumatoid arthritis: Radiologic and clinical study. J Otolaryngol 2003;32(6): 373-378.
35. Segebarth PB, Limbird TJ: Perioperative acute upper airway obstruction secondary to severe rheumatoid arthritis. J Arthroplasty 2007;22(6):916-919.
36. Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT: Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 2009;68(7):1131-1135.
37. Tobin AM, Veale DJ, Fitzgerald O, et al: Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol 2010;37(7):1386- 1394.
38. Solomon DH, Kremer J, Curtis JR, et al: Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010;69(11):1920-1925.
39. Dixon WG, Watson KD, Lunt M, et al: Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56(9):2905-2912.
40. Naranjo A, Sokka T, Descalzo MA, et al: Cardiovascular disease in patients with rheumatoid arthritis: Results from the QUEST-RA study. Arthritis Res Ther 2008;10(2):R30.
41. Greenberg JD, Kremer JM, Curtis JR, et al: Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis 2011;70(4):576-582.
42. Fleisher LA, Beckman JA, Brown KA, et al: 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120(21):e169- e276.
43. Salmon JE, Roman MJ: Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008;121(10 suppl 1):S3-S8.
44. Kwon E, Fleisher LA, Eagle KA: Cardiac risk assessment in noncardiac surgery, in Newman MF, Fleisher LA, Fink MP, eds: Perioperative Medicine: Managing for Outcome. Philadelphia, PA, Saunders, 2008, pp 45-60.
45. Bremander A, Petersson IF, Bergman S, Englund M: Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011;63(4):550-556.
46. Qaseem A, Snow V, Fitterman N, et al: Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: A guideline from the American College of Physicians. Ann Intern Med 2006;144(8):575-580.
47. Bongartz T, Nannini C, Medina- Velasquez YF, et al: Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum 2010;62(6):1583- 1591.
48. Pappas DA, Giles JT, Connors G, Lechtzin N, Bathon JM, Danoff SK: Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: An observational cohort study. Arthritis Res Ther 2010;12(3):R104.
49. Gabbay E, Tarala R, Will R, et al: Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156(2 pt 1):528-535.
50. Meding JB, Keating EM, Ritter MA, Faris PM, Berend ME, Malinzak RA: The planovalgus foot: A harbinger of failure of posterior cruciate-retaining total knee replacement. J Bone Joint Surg Am 2005;87(suppl 2):59-62.
51. Keenan MA, Peabody TD, Gronley JK, Perry J: Valgus deformities of the feet and characteristics of gait in patients who have rheumatoid arthritis. J Bone Joint Surg Am 1991;73(2):237-247.
52. Dixon WG, Suissa S, Hudson M: The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: Systematic review and metaanalyses. Arthritis Res Ther 2011;13(4): R139.
53. Grennan DM, Gray J, Loudon J, Fear S: Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001;60(3):214-217.
54. Visser K, Katchamart W, Loza E, et al: Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009; 68(7):1086-1093.
55. Fuerst M, Möhl H, Baumgärtel K, Rüther W: Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Rheumatol Int 2006;26(12):1138-1142.
56. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S: Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis. J Clin Rheumatol 2003;9(2):115-118.
57. Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT: Leflunomideassociated infections in rheumatoid arthritis. J Rheumatol 2007;34(11): 2201-2203.
58. Jasani MK, Freeman PA, Boyle JA, Downie WW, Wright JH, Buchanan WW: Cardiovascular and plasma cortisol responses to surgery in corticosteroidtreated R. A. patients. Acta Rheumatol Scand 1968;14(1):65-70.
59. Bromberg JS, Alfrey EJ, Barker CF, et al: Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 1991;51(2): 385-390.
60. Leopold SS, Casnellie MT, Warme WJ, Dougherty PJ, Wingo ST, Shott S: Endogenous cortisol production in response to knee arthroscopy and total knee arthroplasty. J Bone Joint Surg Am 2003;85(11):2163-2167.
61. Marik PE, Varon J: Requirement of perioperative stress doses of corticosteroids: A systematic review of the literature. Arch Surg 2008;143(12):1222- 1226.
62. Grijalva CG, Chen L, Delzell E: Initiation of tumor necrosis factor-? antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA 2011;306(21): 2331-2339.
63. van der Goes MC, Jacobs JW, Boers M, et al: Patient and rheumatologist perspectives on glucocorticoids: An exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2010;69(6): 1015-1021.
64. Hoes JN, Jacobs JW, Boers M, et al: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007;66(12): 1560-1567.
65. Giles JT, Bartlett SJ, Gelber AC, et al: Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 2006;55(2): 333-337.
66. den Broeder AA, Creemers MC, Fransen J, et al: Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study. J Rheumatol 2007;34(4):689-695.
67. Curtis JR, Xi J, Patkar N, Xie A, Saag KG, Martin C: Drug-specific and timedependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007;56(12):4226-4227.
68. Galloway JB, Hyrich KL, Mercer LK, et al: Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: Updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford) 2011;50(1):124-131.
69. Galloway JB, Hyrich KL, Mercer LK, et al: Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011;70(10):1810-1814.
70. Furst DE, Keystone EC, Fleischmann R, et al: Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010;69(suppl 1):i2-i29.
71. Scanzello CR, Figgie MP, Nestor BJ, Goodman SM: Perioperative management of medications used in the treatment of rheumatoid arthritis. HSS J 2006;2(2):141-147.
72. Berbari EF, Osmon DR, Carr A, et al: Dental procedures as risk factors for prosthetic hip or knee infection: A hospital-based prospective case-control study. Clin Infect Dis 2010;50(1):8-16.
73. Skaar DD, O'Connor H, Hodges JS, Michalowicz BS: Dental procedures and subsequent prosthetic joint infections: Findings from the Medicare Current Beneficiary Survey. J Am Dent Assoc 2011;142(12):1343-1351.
74. American Academy of Orthopaedic Surgeons, American Dental Association: Prevention of Orthopaedic Implant Infection in Patients Undergoing Dental Procedures: Evidence-Based Guideline and Evidence Report. Available at: http://www.aaos.org/research/guidelines/PUDP/PUDP-guideline.pdf. Accessed April 26, 2013.